Parkinson's disease (PD) is a progressive neurodegenerative disorder that predominantly affects the elderly population. The disease is characterized by a decrease in dopaminergic neurons in the substantia nigra pars compacta, leading to motor and non-motor symptoms.
The hallmark pathophysiological feature of PD is the degeneration of dopaminergic neurons in the substantia nigra. This leads to a decrease in the production of dopamine, a neurotransmitter responsible for regulating movement, mood, and cognition. The exact cause of this degeneration is unknown, but it is believed to involve a combination of genetic and environmental factors.
The classic motor symptoms of PD include bradykinesia, rigidity, and resting tremor. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are also common and can precede motor symptoms. As the disease progresses, patients may develop postural instability leading to falls and difficulty with speech and swallowing.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic therapy. Currently, there is no cure for PD, but medications such as levodopa and dopamine agonists can help manage symptoms. In advanced cases, deep brain stimulation may be considered.
Healthcare professionals play a crucial role in the management of PD. Early recognition and treatment can significantly improve a patient's quality of life. Furthermore, healthcare providers are instrumental in providing patient education and coordinating multidisciplinary care, including physical, occupational, and speech therapy.
Understanding the pathophysiology, clinical manifestations, and management strategies of Parkinson's disease is crucial for healthcare professionals. As the disease continues to affect an increasing number of individuals, the role of healthcare providers in diagnosing, treating, and providing ongoing support to patients with PD becomes increasingly important.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation